Brief: Irlab Therapeutics Q2 Operating Loss Widens To SEK 26.5 Million

IRLAB Therapeutics AB

25/08/2021 06:47

Aug 25 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * Q2 OPERATING LOSS SEK 26.5 MILLION VERSUS LOSS SEK 26.1
MILLION
YEAR AGO

Source text for Eikon:  ID:nMFNJ9Kt1 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))